10/12/2026
Scientific progress has brought new possibilities for children with cancer, but too many families still face limited treatment options and lasting health challenges. The recently released Pediatric Cancer Landscape 2026, a joint report from ACS CAN and the Alliance for Childhood Cancer, examines these gaps and offers policy recommendations to help move research and drug development forward.
Children’s Cancer Cause is proud to contribute as an Alliance member, with our founder, Susan L. Weiner, PhD, serving on the report’s steering committee. Dr. Weiner was part of the committee that authored the original Landscape Report published in 2016. The updated recommendations call for sustained research investment, stronger data sharing, more accessible clinical trials, and solutions to drug-development barriers and chronic shortages -- all with healthy survivorship as a priority.
In our latest blog post, we explore the report’s highlights and how this shared advocacy agenda can inform our work as we look ahead to a new Congress:
A decade of scientific progress has brought new possibilities for children with cancer. But too many families continue to face diagnoses with few effective treatment options, and the majority of survivors live with lasting effects of the therapies that saved their lives. The newly released Pediat